Literature DB >> 21114663

Sensitivity analyses comparing time-to-event outcomes only existing in a subset selected postrandomization and relaxing monotonicity.

Bryan E Shepherd1, Peter B Gilbert, Charles T Dupont.   

Abstract

In randomized studies researchers may be interested in the effect of treatment assignment on a time-to-event outcome that only exists in a subset selected after randomization. For example, in preventative HIV vaccine trials, it is of interest to determine whether randomization to vaccine affects the time from infection diagnosis until initiation of antiretroviral therapy. Earlier work assessed the effect of treatment on outcome among the principal stratum of individuals who would have been selected regardless of treatment assignment. These studies assumed monotonicity, that one of the principal strata was empty (e.g., every person infected in the vaccine arm would have been infected if randomized to placebo). Here, we present a sensitivity analysis approach for relaxing monotonicity with a time-to-event outcome. We also consider scenarios where selection is unknown for some subjects because of noninformative censoring (e.g., infection status k years after randomization is unknown for some because of staggered study entry). We illustrate our method using data from an HIV vaccine trial.
© 2010, The International Biometric Society.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21114663      PMCID: PMC3116075          DOI: 10.1111/j.1541-0420.2010.01508.x

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  11 in total

1.  Intent-to-treat analysis and preventive vaccine efficacy.

Authors:  A D Horne; P A Lachenbruch; K L Goldenthal
Journal:  Vaccine       Date:  2000-09-15       Impact factor: 3.641

Review 2.  Clinical trials of HIV vaccines.

Authors:  Barney S Graham
Journal:  Annu Rev Med       Date:  2002       Impact factor: 13.739

3.  Principal stratification in causal inference.

Authors:  Constantine E Frangakis; Donald B Rubin
Journal:  Biometrics       Date:  2002-03       Impact factor: 2.571

4.  Sensitivity analysis for the assessment of causal vaccine effects on viral load in HIV vaccine trials.

Authors:  Peter B Gilbert; Ronald J Bosch; Michael G Hudgens
Journal:  Biometrics       Date:  2003-09       Impact factor: 2.571

5.  A comparison of eight methods for the dual-endpoint evaluation of efficacy in a proof-of-concept HIV vaccine trial.

Authors:  Devan V Mehrotra; Xiaoming Li; Peter B Gilbert
Journal:  Biometrics       Date:  2006-09       Impact factor: 2.571

6.  Principal stratification designs to estimate input data missing due to death.

Authors:  Constantine E Frangakis; Donald B Rubin; Ming-Wen An; Ellen MacKenzie
Journal:  Biometrics       Date:  2007-09       Impact factor: 2.571

7.  Does Finasteride Affect the Severity of Prostate Cancer? A Causal Sensitivity Analysis.

Authors:  Bryan E Shepherd; Mary W Redman; Donna P Ankerst
Journal:  J Am Stat Assoc       Date:  2008-12-01       Impact factor: 5.033

8.  Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study.

Authors:  Ibou Thior; Shahin Lockman; Laura M Smeaton; Roger L Shapiro; Carolyn Wester; S Jody Heymann; Peter B Gilbert; Lisa Stevens; Trevor Peter; Soyeon Kim; Erik van Widenfelt; Claire Moffat; Patrick Ndase; Peter Arimi; Poloko Kebaabetswe; Patson Mazonde; Joseph Makhema; Kenneth McIntosh; Vladimir Novitsky; Tun-Hou Lee; Richard Marlink; Stephen Lagakos; Max Essex
Journal:  JAMA       Date:  2006-08-16       Impact factor: 56.272

9.  On the analysis of viral load endpoints in HIV vaccine trials.

Authors:  Michael G Hudgens; Antje Hoering; Steven G Self
Journal:  Stat Med       Date:  2003-07-30       Impact factor: 2.373

10.  Sensitivity Analyses Comparing Time-to-Event Outcomes Existing Only in a Subset Selected Postrandomization.

Authors:  Bryan E Shepherd; Peter B Gilbert; Thomas Lumley
Journal:  J Am Stat Assoc       Date:  2007-06       Impact factor: 5.033

View more
  8 in total

1.  Commentary on "Principal stratification - a goal or a tool?" by Judea Pearl.

Authors:  Peter B Gilbert; Michael G Hudgens; Julian Wolfson
Journal:  Int J Biostat       Date:  2011-09-20       Impact factor: 0.968

2.  Sensitivity Analysis of Per-Protocol Time-to-Event Treatment Efficacy in Randomized Clinical Trials.

Authors:  Peter B Gilbert; Bryan E Shepherd; Michael G Hudgens
Journal:  J Am Stat Assoc       Date:  2013-01-01       Impact factor: 5.033

3.  Estimating the efficacy of preexposure prophylaxis for HIV prevention among participants with a threshold level of drug concentration.

Authors:  James Y Dai; Peter B Gilbert; James P Hughes; Elizabeth R Brown
Journal:  Am J Epidemiol       Date:  2013-01-09       Impact factor: 4.897

4.  Post-randomization Biomarker Effect Modification Analysis in an HIV Vaccine Clinical Trial.

Authors:  Peter B Gilbert; Bryan S Blette; Bryan E Shepherd; Michael G Hudgens
Journal:  J Causal Inference       Date:  2020-07-25

5.  Rank-based principal stratum sensitivity analyses.

Authors:  X Lu; D V Mehrotra; B E Shepherd
Journal:  Stat Med       Date:  2013-05-19       Impact factor: 2.373

6.  Comparing competing risk outcomes within principal strata, with application to studies of mother-to-child transmission of HIV.

Authors:  Dustin M Long; Michael G Hudgens
Journal:  Stat Med       Date:  2012-08-28       Impact factor: 2.373

7.  Sharpening bounds on principal effects with covariates.

Authors:  Dustin M Long; Michael G Hudgens
Journal:  Biometrics       Date:  2013-11-18       Impact factor: 2.571

8.  Identification and estimation of survivor average causal effects.

Authors:  Eric J Tchetgen Tchetgen
Journal:  Stat Med       Date:  2014-05-29       Impact factor: 2.373

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.